Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide

Kamolwish Laoprasopwattana1, Pornsak Dissaneewate, Prayong Vachvanichsanong

  • 1Department of Pediatrics, Prince of Songkla University, Songkhla, Thailand. kamolwish@yahoo.com

Insights

Fatal infections in childhood lupus nephritis (LN) patients treated with intravenous cyclophosphamide (IVCY) are linked to prior pulse methylprednisolone, renal failure, and fungal infections. Early identification of fungal infections is crucial for improving outcomes.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • Childhood lupus nephritis (LN) treatment often involves immunosuppressants like intravenous cyclophosphamide (IVCY).
  • Severe infections pose a significant risk to patients with LN undergoing immunosuppressive therapy.
  • Understanding risk factors for fatal infections is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To identify the causes and risk factors associated with fatal infections in children with lupus nephritis treated with IVCY.
  • To inform clinical practice and improve patient outcomes by elucidating predictors of mortality.

Main Methods:

  • Retrospective analysis of 84 childhood lupus nephritis patients treated between 1996-2007.
  • Detailed review of severe infection episodes, causative organisms, and patient characteristics.
  • Multivariate analysis to determine independent risk factors for fatal infections.

Main Results:

  • 36.9% of patients experienced severe infections, with a 41.9% mortality rate among those infected.
  • Major causes of fatal infections included fungi and Gram-negative bacilli.
  • Risk factors for fatal infection included prior pulse methylprednisolone, renal failure, and fungal infection.

Conclusions:

  • Prior pulse methylprednisolone, renal failure, and fungal infections are significant predictors of fatal outcomes in childhood LN patients on IVCY.
  • Aggressive investigation for fungal infections is warranted in patients with active LN, IVCY, and pulse methylprednisolone who develop severe, antibiotic-refractory infections.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...